Page last updated: 2024-10-24

celecoxib and Burkitt Lymphoma

celecoxib has been researched along with Burkitt Lymphoma in 3 studies

Burkitt Lymphoma: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.

Research Excerpts

ExcerptRelevanceReference
"Celecoxib can inhibit the proliferation of Raji cells in a dose-dependent and time-dependent manner."1.36[Effect of celecoxib and adriamycin on proliferation and apoptosis of Raji cells and its mechanism]. ( Fu, B; Huang, R; Huang, X; Li, X; Yang, X, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, X1
Li, X1
Huang, R1
Yang, X1
Fu, B1
Kardosh, A2
Wang, W2
Uddin, J1
Petasis, NA1
Hofman, FM1
Chen, TC2
Schönthal, AH2
Su, YS1

Other Studies

3 other studies available for celecoxib and Burkitt Lymphoma

ArticleYear
[Effect of celecoxib and adriamycin on proliferation and apoptosis of Raji cells and its mechanism].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2010, Volume: 35, Issue:10

    Topics: Apoptosis; Burkitt Lymphoma; Caspase 9; Celecoxib; Cell Line, Tumor; Cell Proliferation; Dose-Respon

2010
Dimethyl-celecoxib (DMC), a derivative of celecoxib that lacks cyclooxygenase-2-inhibitory function, potently mimics the anti-tumor effects of celecoxib on Burkitt's lymphoma in vitro and in vivo.
    Cancer biology & therapy, 2005, Volume: 4, Issue:5

    Topics: Animals; Antineoplastic Agents; Burkitt Lymphoma; Celecoxib; Cell Cycle Proteins; Cell Line, Tumor;

2005
Efficacy of celecoxib in the treatment of CNS lymphomas: an in vivo model.
    Neurosurgical focus, 2006, Nov-15, Volume: 21, Issue:5

    Topics: Animal Feed; Animals; Apoptosis; Burkitt Lymphoma; Celecoxib; Cell Line, Tumor; Central Nervous Syst

2006